Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by studpuppyon Aug 22, 2011 1:27pm

345 Views

Post# 18967234

RE: RE: RE: Short Covering

now now rusty lets not get to naive here...those shares are being fed to goldman by bmo and desjardins lately, look at all those shares that keep on popping at $4 with over 129k shares being traded, don`t worry when all of huss`s buddy`s get their pockets full of cheap shares then and only then we will move higher, they are not done yet!!!
had they issued those shares with the nasdaq listing i assure you we wouldn`t be here right now....
regards stud

Bullboard Posts

Changing Europe’s dependency on HREE from China